Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
65 participants
OBSERVATIONAL
2024-07-01
2025-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* To compare the functional capacity of T regs in LN and in normal individuals.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prediction of Lupus Renal Flares Study
NCT05362812
Urinary T Cell Biomarker for Prediction in Lupus Nephritis
NCT04320797
Autologous Polyclonal Tregs for Lupus
NCT02428309
Identifying New Therapeutic Targets for Lupus Treatment
NCT03921398
A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus
NCT06106893
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with active lupus nephritis
patients with active lupus nephritis as active urinary sediment, or rising renal chemistry
T-reg cells
laboratory test
patients with lupus nephritis in remission
Patients who were previously active, but now in remission
T-reg cells
laboratory test
normal individuals
normal healthy participants
T-reg cells
laboratory test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
T-reg cells
laboratory test
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed AbdEllah Ahmed Hussein
Principal Investigator
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Doglio M, Alexander T, Del Papa N, Snowden JA, Greco R; Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT). New insights in systemic lupus erythematosus: From regulatory T cells to CAR-T-cell strategies. J Allergy Clin Immunol. 2022 Dec;150(6):1289-1301. doi: 10.1016/j.jaci.2022.08.003. Epub 2022 Sep 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
T cells in lupus LN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.